222
Participants
Start Date
June 30, 2011
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
Irinotecan, Capecitabine
"Irinotecan 80 mg/m2, day 1 and 8, every 3 weeks~\+ capecitabine 1000 mg/m2, BID, day 1-14, every 3 weeks"
RECRUITING
National Cancer Center, Goyang-si
Collaborators (1)
Asan Medical Center
OTHER
Chung-Ang University
OTHER
Inha University Hospital
OTHER
Korea University Anam Hospital
OTHER
Samsung Medical Center
OTHER
Severance Hospital
OTHER
Seoul National University Hospital
OTHER
Seoul National University Bundang Hospital
OTHER
National Cancer Center, Korea
OTHER_GOV